Cost-Effectiveness Analyses of an Absorbable Antibacterial Envelope for Use in Patients at Increased Risk of Cardiac Implantable Electronic Device Infection in Germany, Italy, and England
Open Access
- 1 April 2021
- journal article
- research article
- Published by Elsevier BV in Value in Health
- Vol. 24 (7), 930-938
- https://doi.org/10.1016/j.jval.2020.12.021
Abstract
No abstract availableKeywords
Funding Information
- Medtronic Inc
- Medtronic
This publication has 34 references indexed in Scilit:
- A simple infection-control protocol to reduce serious cardiac device infectionsEP Europace, 2014
- Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in DenmarkEuropean Heart Journal, 2013
- 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapyEuropean Heart Journal, 2013
- Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm AssociationEuropean Heart Journal, 2013
- Mortality and Cost Associated With Cardiovascular Implantable Electronic Device InfectionsArchives of Internal Medicine, 2011
- Cardiac device infections are associated with a significant mortality riskHeart Rhythm, 2011
- 16-Year Trends in the Infection Burden for Pacemakers and Implantable Cardioverter-Defibrillators in the United States: 1993 to 2008Journal of the American College of Cardiology, 2011
- Economic evaluation in cardiologyEP Europace, 2011
- Prevalence and risk factors related to infections of cardiac resynchronization therapy devicesEuropean Heart Journal, 2009
- Proposta di linee guida per la valutazione economica degli interventi sanitari in ItaliaPharmacoEconomics Italian Research Articles, 2009